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HISTOLOGICAL GRADING (Bloom &
Richardson, 1957; Freedman et al., 1979)
and clinical staging (Fisher et al., 1975;
Langlands & Kerr, 1978) are both strongly
related to prognosis in human breast
carcinoma. There is, however, surprisingly
little information on the relationship
beween the two, though Hamlin (1968)
suggested that staging might to a certain
extent be a clinical measure of grading.
The present series consists of 297 cases;
the primary tumours had been staged
clinically (IUAC, 1972) and graded histo-
logically (Scarff & Torloni, 1968).
TABLE I.-Five-year survival (0/O) related to
TNM status and histological grade (31
patients dying of unrelated diseases are
excluded)
Five-year
survival (%)
TNM
1 2 3 4
97 65 54 14
The 5-year survival (Table I) decreased
steadily with both increasing stage
(Langlands & Kerr, 1978) and grade
(Freedman et al., 1979). Tumour size
increased with increasing grade (I,
2*4cm+ 1 4; II, 3 0 cm+ 1-4; JII,3A4cm+
1.6) in keeping with Fisher et al. (1980).
The main finding here (Table II) was
that tumours of high grade tended to
present at a later stage than those of low
grade, implying a fixed relationship be-
tween tumour progress before and after
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TABLE II.-The relation between histologi-
cal grade and TNM status (4), x2 giving
p<o0001
Grade
I
II
III
TNM stage
A_
1 2 3 4
49 22 14 12
34 50 48 20
17 28 38 68
presentation. This confirms and supple-
ments the earlier report from this Institute
(Thoresen et al., 1981) based on a further
series of 222 cases, and is in keeping with
the suggestion that "it is plausible to
suppose some correlation between the rate
of growth in the presymptomatic period
and that during the subsequent course"
(Lancet, 1981).
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Grade factors analysed, the "score" being related
I II III to TNMI status (Factor 1, tubule forma-
tion; Factor 2, hyperchromatism and
88 72 44 mitosis; Factor 3, irregularity of size,
shape and staining ofnuclei)
Factor 1
1 point
2 points
3 points
Factor 2
1 point
2 points
3 points
Factor 3
1 point
2 points
3 points
TNM
1 2 3 4
29
29
42
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36
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21
45
25
20
40
40
38
40
22
17
56
27
11
54
35
41
30
29
7
65
28
9
27
66
14
27
59
9
36
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Breaking up the grades into 3 different
factors (Table III) showed that Factor 2
(hyperchromatism and mitosis) was the
most important for prognosis, especially in
Stages I and II. The association of
hyperchromatism and mitosis with high-
grade tumours, and its further association
with advanced stage at presentation is
logical, as the intrinsic rate of progress of
tumours ofthis type is high. This has been
shown previously in the relationship to
survival time after presentation. It is thus
not surprising that this should have had
similar influence in the preclinical phase.
This goes far to explain the rationale
behind Shimkin's (1969) statement that
"the overwhelming single determinant of
prognosis is the stage of the disease at
initial definitive treatment".
My thanks are due to Professor F. Hartveit for
permission to use material in the Norwegian Cancer
Society's register collected previously.
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